China Resources Sanjiu Medical & Pharmaceutical Co Ltd Net Assets

Latest as of June 2026: CN¥39.13 Billion CNY ≈ $5.73 Billion USD

China Resources Sanjiu Medical & Pharmaceutical Co Ltd net assets. Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has net assets worth CN¥39.13 Billion CNY (≈ $5.73 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥55.84 Billion ≈ $8.17 Billion USD) and total liabilities (CN¥16.71 Billion ≈ $2.45 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of China Resources Sanjiu Medical & Pharmac to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥39.13 Billion
% of Total Assets 70.08%
Annual Growth Rate 16.26%
5-Year Change 145.79%
10-Year Change 344.56%
Growth Volatility 46.95

Net Assets of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2025)

Net assets of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025. This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. See China Resources Sanjiu Medical & Pharmac (000999) balance sheet quality index to measure how much of total assets are equity-financed.

Annual Net Assets for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2025)

The table below shows the annual net assets of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025. For live market cap and overall valuation, see market value of China Resources Sanjiu Medical & Pharmac.

Year Net Assets Change
2025-12-31 CN¥38.77 Billion
≈ $5.67 Billion		 +53.51%
2024-12-31 CN¥25.26 Billion
≈ $3.70 Billion		 +4.10%
2023-12-31 CN¥24.26 Billion
≈ $3.55 Billion		 +38.38%
2022-12-31 CN¥17.53 Billion
≈ $2.57 Billion		 +11.15%
2021-12-31 CN¥15.77 Billion
≈ $2.31 Billion		 +12.26%
2020-12-31 CN¥14.05 Billion
≈ $2.06 Billion		 +7.44%
2019-12-31 CN¥13.08 Billion
≈ $1.91 Billion		 +17.10%
2018-12-31 CN¥11.17 Billion
≈ $1.63 Billion		 +10.26%
2017-12-31 CN¥10.13 Billion
≈ $1.48 Billion		 +16.15%
2016-12-31 CN¥8.72 Billion
≈ $1.28 Billion		 +13.65%
2015-12-31 CN¥7.67 Billion
≈ $1.12 Billion		 +9.70%
2014-12-31 CN¥7.00 Billion
≈ $1.02 Billion		 +12.89%
2013-12-31 CN¥6.20 Billion
≈ $906.76 Million		 +10.52%
2012-12-31 CN¥5.61 Billion
≈ $820.42 Million		 +15.59%
2011-12-31 CN¥4.85 Billion
≈ $709.79 Million		 +2.51%
2010-12-31 CN¥4.73 Billion
≈ $692.38 Million		 +19.74%
2009-12-31 CN¥3.95 Billion
≈ $578.22 Million		 +15.89%
2008-12-31 CN¥3.41 Billion
≈ $498.95 Million		 +15.26%
2007-12-31 CN¥2.96 Billion
≈ $432.89 Million		 +13.44%
2006-12-31 CN¥2.61 Billion
≈ $381.59 Million		 +9.00%
2005-12-31 CN¥2.39 Billion
≈ $350.07 Million		 +4.57%
2004-12-31 CN¥2.29 Billion
≈ $334.78 Million		 -24.94%
2003-12-31 CN¥3.05 Billion
≈ $446.03 Million		 +2.56%
2002-12-31 CN¥2.97 Billion
≈ $434.90 Million		 +0.67%
2001-12-31 CN¥2.95 Billion
≈ $432.00 Million		 +2.95%
2000-12-31 CN¥2.87 Billion
≈ $419.64 Million		 +8.07%
1999-12-31 CN¥2.65 Billion
≈ $388.31 Million		 +255.19%
1998-12-31 CN¥747.10 Million
≈ $109.32 Million		 +30.92%
1997-12-31 CN¥570.67 Million
≈ $83.51 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1863875100000.0% over the analyzed period, indicating profitable operations and earnings retention.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Net Assets Breakdown (December 2025)

China Resources Sanjiu Medical & Pharmaceutical Co Ltd net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings CN¥18.64 Billion 84.07%
Common Stock CN¥1.66 Billion 7.51%
Other Comprehensive Income CN¥1.10 Billion 4.94%
Other Components CN¥773.61 Million 3.49%
Total Equity CN¥22.17 Billion 100.00%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their market capitalization.

Company Market Cap
YANGTZE OPT.FIB.AND CAB.H
F:1YO
 $6.26 Billion
Bank of Suzhou
SHE:002966
 $6.26 Billion
Schaeffler AG
XETRA:SHA0
 $6.26 Billion
VSXY
NYSE:VSXY
 $6.27 Billion
Haohua Chemical Science & Technology Corp Ltd
SHG:600378
 $6.25 Billion
Indian Overseas Bank
NSE:IOB
 $6.25 Billion
Inner Mongolia Xingye Mining Co Ltd
SHE:000426
 $6.25 Billion
Hebei Yangyuan ZhiHui Beverage Co Ltd
SHG:603156
 $6.24 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in China Resources Sanjiu Medical & Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 19,903,111,306 to 22,171,741,000, a change of 2,268,629,694 (11.4%).
  • Net income of 3,421,788,000 contributed positively to equity growth.
  • Dividend payments of 1,255,790,877 reduced retained earnings.
  • Share repurchases of 35,150,953 reduced equity.
  • Other comprehensive income increased equity by 1,095,161,000.
  • Other factors decreased equity by 957,377,476.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥3.42 Billion +15.43%
Dividends Paid CN¥1.26 Billion -5.66%
Share Repurchases CN¥35.15 Million -0.16%
Other Comprehensive Income CN¥1.10 Billion +4.94%
Other Changes CN¥-957.38 Million -4.32%
Total Change CN¥- 11.40%

Book Value vs Market Value Analysis

This analysis compares China Resources Sanjiu Medical & Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.92x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 62.93x to 1.92x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.41 CN¥25.67 x
1998-12-31 CN¥0.55 CN¥25.67 x
1999-12-31 CN¥2.02 CN¥25.67 x
2000-12-31 CN¥1.98 CN¥25.67 x
2001-12-31 CN¥2.05 CN¥25.67 x
2002-12-31 CN¥2.18 CN¥25.67 x
2003-12-31 CN¥2.25 CN¥25.67 x
2004-12-31 CN¥1.66 CN¥25.67 x
2005-12-31 CN¥1.75 CN¥25.67 x
2006-12-31 CN¥1.93 CN¥25.67 x
2007-12-31 CN¥2.12 CN¥25.67 x
2008-12-31 CN¥2.52 CN¥25.67 x
2009-12-31 CN¥2.88 CN¥25.67 x
2010-12-31 CN¥3.51 CN¥25.67 x
2011-12-31 CN¥3.59 CN¥25.67 x
2012-12-31 CN¥5.46 CN¥25.67 x
2013-12-31 CN¥5.02 CN¥25.67 x
2014-12-31 CN¥4.09 CN¥25.67 x
2015-12-31 CN¥4.59 CN¥25.67 x
2016-12-31 CN¥5.19 CN¥25.67 x
2017-12-31 CN¥5.95 CN¥25.67 x
2018-12-31 CN¥6.53 CN¥25.67 x
2019-12-31 CN¥7.70 CN¥25.67 x
2020-12-31 CN¥8.28 CN¥25.67 x
2021-12-31 CN¥9.26 CN¥25.67 x
2022-12-31 CN¥10.19 CN¥25.67 x
2023-12-31 CN¥11.40 CN¥25.67 x
2024-12-31 CN¥11.96 CN¥25.67 x
2025-12-31 CN¥13.35 CN¥25.67 x

Capital Efficiency Dashboard

This dashboard shows how efficiently China Resources Sanjiu Medical & Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 15.43%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 10.83%
  • • Asset Turnover: 0.54x
  • • Equity Multiplier: 2.65x
  • Recent ROE (15.43%) is above the historical average (11.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 19.03% 8.90% 0.76x 2.83x CN¥46.89 Million
1998 21.71% 10.58% 0.84x 2.46x CN¥81.35 Million
1999 8.55% 14.92% 0.41x 1.39x CN¥-37.37 Million
2000 6.41% 9.91% 0.29x 2.26x CN¥-90.51 Million
2001 4.65% 6.48% 0.28x 2.53x CN¥-139.36 Million
2002 5.96% 7.62% 0.32x 2.47x CN¥-111.87 Million
2003 7.29% 7.81% 0.32x 2.90x CN¥-77.56 Million
2004 -34.10% -29.28% 0.34x 3.40x CN¥-932.18 Million
2005 5.27% 3.97% 0.42x 3.15x CN¥-105.52 Million
2006 6.72% 5.75% 0.40x 2.90x CN¥-80.38 Million
2007 10.07% 8.23% 0.43x 2.86x CN¥2.08 Million
2008 15.64% 11.59% 0.84x 1.60x CN¥180.38 Million
2009 19.25% 14.62% 0.86x 1.53x CN¥340.86 Million
2010 18.21% 18.69% 0.66x 1.47x CN¥367.91 Million
2011 16.73% 13.94% 0.72x 1.67x CN¥305.95 Million
2012 19.12% 14.71% 0.80x 1.62x CN¥487.06 Million
2013 18.53% 15.20% 0.73x 1.67x CN¥510.35 Million
2014 15.32% 14.24% 0.68x 1.58x CN¥359.89 Million
2015 16.50% 15.81% 0.66x 1.59x CN¥492.06 Million
2016 13.90% 13.34% 0.66x 1.57x CN¥336.34 Million
2017 13.22% 11.71% 0.69x 1.65x CN¥317.34 Million
2018 13.23% 10.67% 0.74x 1.67x CN¥349.31 Million
2019 16.45% 14.19% 0.69x 1.68x CN¥822.84 Million
2020 11.64% 11.71% 0.62x 1.61x CN¥225.52 Million
2021 13.42% 13.22% 0.63x 1.60x CN¥523.79 Million
2022 14.40% 13.54% 0.67x 1.59x CN¥747.84 Million
2023 15.04% 11.53% 0.62x 2.12x CN¥956.22 Million
2024 16.92% 12.20% 0.69x 2.01x CN¥1.38 Billion
2025 15.43% 10.83% 0.54x 2.65x CN¥1.20 Billion

Industry Comparison

This section compares China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,124,889,896
  • Average return on equity (ROE) among peers: 7.89%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) CN¥39.13 Billion 19.03% 0.43x $6.25 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $902.62 Million 5.17% 3.60x $492.82 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.56 Billion 7.90% 1.45x $363.79 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $366.91 Million 9.97% 0.26x $4.71 Billion
Livzon Pharmaceutical Group Inc (000513) $14.91 Billion 13.83% 0.64x $2.63 Billion
Wedge Industrial Co Ltd (000534) $654.70 Million 1.92% 0.87x $1.28 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $14.36 Billion
Hainan Haiyao Co Ltd (000566) $317.39 Million 7.74% 0.74x $766.98 Million
Tus Pharmaceutical Group Co Ltd (000590) $268.54 Million 1.60% 1.47x $273.68 Million
Northeast Pharmaceutical Group Co Ltd (000597) $889.22 Million 5.34% 2.43x $935.44 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.35 Billion 7.34% 0.44x $3.04 Billion

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$6.25 Billion
CN¥42.72 Billion CNY
Market Cap Rank
#3004 Global
#341 in China
Share Price
CN¥25.67
Change (1 day)
-0.77%
52-Week Range
CN¥22.16 - CN¥30.53
All Time High
CN¥1328.34
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug prod… Read more